Compound information
- Natural Products
- ZC1707949
- Molecular Formula
- C19H24N4O
- Molecular Weight
- 324.195011388 g/mol
- Structure
-
- IUPAC Name
- N-(3,5-dimethylphenyl)-4-(3-pyridylmethyl)piperazine-1-carboxamide
- InChI
- InChI=1S/C19H24N4O/c1-15-10-16(2)12-18(11-15)21-19(24)23-8-6-22(7-9-23)14-17-4-3-5-20-13-17/h3-5,10-13H,6-9,14H2,1-2H3,(H,21,24)
- InChI Key
- YNISEJBTKYHZDO-UHFFFAOYSA-N
- SMILES
- Cc1cc(C)cc(NC(=O)N2CCN(Cc3cccnc3)CC2)c1
- Source
- ZINC000013325073
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 3 |
Heteroatom Count | 5 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 48.47 Å2 | LogP | 2.58 |
LogS | -2.446 | LogD | 3.245 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.994 | Pgp substrate | 0.765 |
HIA | 0.966 | F20 % | 0.939 |
F30 % | 0.908 | Caco-2 | -4.89 |
MDCK | -5.598 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.932 | PPB | 98.999 |
VD | 1.344 | Fu | 0.642 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.003 | CYP1A2 substrate | 0.648 |
CYP2A6 substrate | 0.763 | CYP2B6 substrate | 0.514 |
CYP2C19 inhibitor | 0.852 | CYP2C19 substrate | 0.942 |
CYP2C8 substrate | 0.864 | CYP2C9 inhibitor | 0.641 |
CYP2C9 substrate | 0.068 | CYP2D6 inhibitor | 0.779 |
CYP2D6 substrate | 0.692 | CYP2E1 substrate | 0.2 |
CYP3A4 inhibitor | 0.952 | CYP3A4 substrate | 0.97 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.802 | CL | 11.216 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.803 | Hepatotoxicity | 0.859 |
Mutagenicity | 0.002 | Rat Oral Acute Toxicity | 0.836 |
FDAMDD | 0.675 | Skin Sensitization | 0.994 |
Carcinogenicity | 0.143 | Eye Corrosion | 0.003 |
Eye Irritation | 0.002 | Respiratory Toxicity | 0.954 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.801 | IGC50 | 3.134 |
LC50FM | 3.748 | LC50DM | -0.986 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.404 | NR-AR-LBD | 0.189 |
NR-AhR | 0.71 | NR-Aromatase | 0.025 |
NR-ER | 0.315 | NR-ER-LBD | 0.284 |
NR-PPAR-gamma | 0.152 | SR-ARE | 0.841 |
SR-ATAD5 | 0.318 | SR-HSE | 0.128 |
SR-MMP | 0.016 | SR-p53 | 0.043 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.